Dechra Pharmaceuticals shares fall despite stronger than expected revenue growth
- Record year as revenues jump 14%- Despite macro uncertainties, market remains resilient- Company continues to outperform the market Specialist veterinary pharmaceuticals company Dechra Pharmaceuticals (DPH) said it traded in line...
11 July 2022